Summary | It's a narrative that has played out before. Biotech
stocks, favorites of fast-money hedge-fund traders, lead the
market higher, and then, suddenly, they tumble.
stocks, favorites of fast-money hedge-fund traders, lead the
market higher, and then, suddenly, they tumble.
blogs.wsj.com | 30 April 2015